pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
RT-200
Type 2 Diabetes
Renova Therapeutics Inc
Phase 1
RTT-1
Rett Syndrome
Grann Pharmaceuticals Inc
Phase 3
RTX-015
Retinitis Pigmentosa (Retinitis)
Ray Therapeutics Inc
RUXIENCE
← prev
page 128 of 231
next →
131
Pain
89
Neurology
1
RUXIENCE (RITUXIMAB-PVVR)
no indication
$PFE
PFIZER INC
Phase 2
RV-01
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Ventures LLC
Phase 1
RV-1770
Respiratory Syncytial Virus (RSV) Infections
Hualan Biological Vaccine Inc
Preclinical
RVB-001
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
Preclinical
RVB-003
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
Phase 2
RX-0301
Hepatocellular Carcinoma
Zhejiang Haichang Biotechnology Co Ltd
Phase 2
RXRG-001
Xerostomia
RiboX (Shanghai) Therapeutics Co Ltd
Phase 2
RY-104
Wet (Neovascular / Exudative) Macular Degeneration
Neuracle Genetics Inc
Phase 2
RZ-001
Glioblastoma Multiforme (GBM)
Rznomics Inc
Phase 2
Radspherin
Colorectal Cancer
Oncoinvent ASA
Phase 3
ReNu
Osteoarthritis
$ORGO
Organogenesis Holdings Inc.
Preclinical
Recombinant AAT
Charcot-Marie-Tooth Disease Type I A
Ageronix SA
Preclinical
Recombinant Alpha-1 Antitrypsin Replacement for Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (A1AD)
Caravella Biopharma SA
Preclinical
Recombinant Human Neuroglobin (rNgb)
Carbon Monooxide Poisoning
Globin Solutions Inc
Preclinical
Recombinant Peptide to Inhibit Type I Collagen for Frozen Shoulder Syndrome
Frozen Shoulder Syndrome
Ortholevo Inc
Preclinical
Recombinant Protein to Activate p38 MAP Kinase for Round Worm Infections
Nematodal (Round Worm) Infections
University of California San Diego
Preclinical
Recombinant Protein to Antagonize TGF beta for Immunology, Dermatology, Gastrointestinal and Musculoskeletal Disorders
Oral Mucositis
Allander Biotechnologies LLC
Marketed
Regenecyte
Regenecyte
Blood Cancer
StemCyte Inc
Preclinical
Rejuvenated Stem Cell Therapy
Bone Marrow Transplant Rejection
Hexem Bio Inc
Marketed
Relexxii
Relexxii (methylphenidate hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Vertical Pharmaceuticals LLC
Phase 2
Remygen
Type 1 Diabetes (Juvenile Diabetes)
Diamyd Medical AB
Phase 3
Restem-L
Dermatomyositis
RESTEM Group Inc
Marketed
Rethymic
Rethymic
DiGeorge Syndrome
Sumitomo Pharma America Inc
Phase 2
ReversPAH
Pulmonary Arterial Hypertension
Artin Bioscience Inc
Marketed
Rezipres
Rezipres (ephedrine hydrochloride)
Hypotension
Dr. Reddy's Laboratories Ltd
Preclinical
RgnA-09M
Osteoarthritis
Regenosine Inc
Phase 1
RiVax
RiVax
Poisoning
$SNGX
SOLIGENIX, INC.
